| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 1436-1443, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
J Itoh, M Nose, S Takahashi, M Ono, S Terasaki, E Kondoh and M Kyogoku
Department of Pathology, Tohoku University School of Medicine, Sendai, Japan.
MRL/Mp-lpr/lpr(MRL/lpr) lupus mice develop glomerulonephritis in which the histopathological manifestations of the disease are characterized by diffuse cell-proliferative, crescentic, and/or wire loop-like lesions, resembling those of human lupus nephritis. Although these lesions are thought to be mediated by antibodies, little data is available to explain these regular variations in glomerular lesions induced by antibodies at the monoclonal level. We studied glomerular lesions of normal or severe combined immunodeficient mice injected with nephritogenic immunoglobulin G3-producing hybridoma clones (2B11.3 and 7B6.8), which we previously established from an unmanipulated MRL/lpr mouse. Both clones caused increased serum levels of immunoglobulin G3 with identical patterns over time and both induced glomerular deposits of immunoglobulin G3 and C3. However, 2B11.3 and 7B6.8 induced glomerular lesions that differed in their histopathological manifestations. The 2B11.3 clone generated cell-proliferative lesions associated with marked Mac-2-positive macrophage infiltrates, but the 7B6.8 clone induced lesions characterized by subendothelial hyaline deposits resembling wire loops. The latter was not associated with significant inflammatory cell infiltrates at any point throughout the progression of the lesion. Thus, our findings suggest that the histopathological variation in glomerulonephritis seen in MRL/lpr mice results from clonally expanded B cell clones that produce nephritogenic antibodies with different pathogenic potencies.
This article has been cited by other articles:
![]() |
W. Shiroiwa, K. Tsukamoto, M. Ohtsuji, Q. Lin, A. Ida, S. Kodera, N. Ohtsuji, K. Nakamura, H. Tsurui, K. Kinoshita, et al. IL-4R{alpha} polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus Int. Immunol., February 1, 2007; 19(2): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kuroda, A. Kuroki, S. Kikuchi, T. Funase, M. Nakata, and S. Izui A Critical Role for Sialylation in Cryoglobulin Activity of Murine IgG3 Monoclonal Antibodies J. Immunol., July 15, 2005; 175(2): 1056 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kikuchi, Y. Pastore, L. Fossati-Jimack, A. Kuroki, H. Yoshida, T. Fulpius, K. Araki, S. Takahashi, R. Lemoine, L. Reininger, et al. A Transgenic Mouse Model of Autoimmune Glomerulonephritis and Necrotizing Arteritis Associated with Cryoglobulinemia J. Immunol., October 15, 2002; 169(8): 4644 - 4650. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mizuochi, Y. Pastore, K. Shikata, A. Kuroki, S. Kikuchi, T. Fulpius, M. Nakata, L. Fossati-Jimack, L. Reininger, M. Matsushita, et al. Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins Blood, June 1, 2001; 97(11): 3537 - 3543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-U. Rengers, G. Touchard, C. Decourt, S. Deret, H. Michel, and M. Cogne Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia Blood, June 1, 2000; 95(11): 3467 - 3472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Aronica, A Dozier, P Fanti, and M Nazareth Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin Lupus, May 1, 2000; 9(4): 271 - 277. [Abstract] [PDF] |
||||
![]() |
L. Fossati-Jimack, A. Ioan-Facsinay, L. Reininger, Y. Chicheportiche, N. Watanabe, T. Saito, F. M. A. Hofhuis, J. E. Gessner, C. Schiller, R. E. Schmidt, et al. Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact In Vivo with the Low-Affinity Fc{gamma} Receptor III J. Exp. Med., April 10, 2000; 191(8): 1293 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Seery, J. M. Carroll, V. Cattell, and F. M. Watt Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon gamma in the Epidermis J. Exp. Med., November 3, 1997; 186(9): 1451 - 1459. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |